Senior insider sale
Chief Executive Officer at CENTESSA PHARMACEUTICALS PLC — senior position signals high conviction
$108.89M
4.80M shares
SAHA SAURABH plans to sell 4.80M shares of CENTESSA PHARMACEUTICALS PLC valued at approximately $108.89M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Stock Option Exercise
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/21/2026 | Stock Option Exercise Cash | 2.30M | — |
| Total | 2.30M | ||
Completed
Units to sell
358.79K
Market value
$8.06M
Units to sell
1.10M
Market value
$24.67M
Units to sell
126.91K
Market value
$2.79M
Units to sell
86.49K
Market value
$1.92M
Units to sell
45.68K
Market value
$1.00M
Units to sell
121.62K
Market value
$2.74M
Units to sell
118.42K
Market value
$2.62M
Units to sell
147.46K
Market value
$3.35M
Units to sell
122.39K
Market value
$2.80M
Units to sell
147.92K
Market value
$3.36M
Units to sell
124.33K
Market value
$2.98M
Planned — Approximate Date
Units to sell
2.30M
Market value
$52.60M
Units
4.80M
Value
$108.89M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/16/2026 | 358.79K | $8.06M | — | Completed |
1/15/2026 | 1.10M | $24.67M | — | Completed |
1/14/2026 | 126.91K | $2.79M | — | Completed |
1/13/2026 | 86.49K | $1.92M | — | Completed |
1/12/2026 | 45.68K | $1.00M | — | Completed |
1/9/2026 | 121.62K | $2.74M | — | Completed |
1/8/2026 | 118.42K | $2.62M | — | Completed |
1/7/2026 | 147.46K | $3.35M | — | Completed |
1/6/2026 | 122.39K | $2.80M | — | Completed |
1/5/2026 | 147.92K | $3.36M | — | Completed |
1/2/2026 | 124.33K | $2.98M | — | Completed |
| Planned — Approximate Date | ||||
1/21/2026 | 2.30M | $52.60M | NASDAQ | Planned |
| Total | 4.80M | $108.89M | ||